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ORIGINAL INVESTIGATION risk of PrU development. If patients who are at risk for a PrU can be predicted, their care can be tailored to prevent unnecessary complications and suffering, as well as save considerable cost. 11 The need for a valid and reliable PrU risk assessment scale that is applicable to the clinical setting is undeniable. To date, the most commonly adopted scales have been the Braden, 12 Gosnell, 13 Norton, 10 and Waterlow 14 scales. Each scale has been reported to have predictive value and applicability in various clinical settings [10] [11] [12] [13] [14] ; however, no clinical trial has compared the predictive power of these 4 scales. 15 The present study sought to do this, and to identify a valid and reliable PrU risk assessment scale suitable for use in the hospital setting.
METHODS
Between January 2000 and December 2002, a total of 230 patients from the neurology, intensive care, orthopedic, and medical units of 3 educational hospitals in Kermanshah, Iran, participated in the study. Subjects included patients ages 21 years and older who had been admitted to the hospital within the past 48 hours, who were expected to stay in the hospital for 14 days or longer, and who did not have a PrU detected during the initial skin assessment. Subjects who were expected to stay in the hospital less than 14 days and who had a PrU on admission were excluded from the study. The 14-day observation period was based on the methods used by Pang and Wong, 16 whose work suggests that the critical period for PrU development is the first 14 days after admission.
After consent was obtained from the subjects or their significant others, an initial PrU assessment was performed for each within 48 hours of admission using 4 PrU risk assessment scales: the Braden, Gosnell, Norton, and Waterlow scales. After the initial assessment, a subject's skin was assessed once every 24 hours for a minimum of 14 days to identify any skin breakdown.
Instruments
The Braden Scale 12 is a summated rated scale comprised of 6 subscales: sensory perception, mobility, activity, moisture, nutrition, and friction and shear. The 6 subscales are rated from 1 to 4, except the friction and shear subscale, which is rated from 1 to 3. Each numerical rating has a definition of patient characteristics to evaluate when assigning a score. A total of 6 to 23 points is possible. The original critical cut-off point for diagnosing risk is 16. 12 Other investigators have suggested 18 as a cut-off score for older patients and African American and Latino patients. [17] [18] [19] The Gosnell Scale 13 consists of 5 parameters-mental status, continence, mobility, activity, and nutrition-with varying points (1 to 3 for nutrition; 1 to 4 for continence, mobility, and activity; and 1 to 5 for mental status). The scoring for each parameter is clarified by brief descriptive statements. The Gosnell Scale documents additional variables, including body vital signs, skin appearance, diet, 24-hour fluid balance, medication, and interventions; however, these variables are not given weight in the final score. Possible scores for the Gosnell Scale range from 5 to 20. Although early studies reported that lower scores denoted a higher risk, 16 has been established as the critical cut-off score. 13 The first PrU risk assessment scale, the Norton Scale 10 consists of 5 parameters: physical condition, mental state, activity, mobility, and incontinence. Each parameter is rated on a scale from 1 to 4, with a 1-, 2-, or 3-word descriptor for each rating. The sum of the ratings for all 5 parameters yields a score ranging from 5 to 20, with lower scores indicating an increased risk. A score of 16 or lower indicates a risk for PrU formation. 10 The Waterlow Scale 14 is based on the Norton Scale, but is considered to be more comprehensive. The Waterlow Scale consists of 8 items: build/weight for height, visual assessment of the skin in the area at risk, sex and age, continence, mobility, appetite, medication, and special risk factors. The highest and lowest scores of each item vary. For instance, the scores for mobility range from 0 to 5; scores for appetite range from 0 to 3. Patients scoring 10 to 14 are identified as being at risk for PrU formation. A score of 16 or above is the usual cut-off point for at-risk patients in clinical studies. 14 
Skin assessment chart
In addition to the scales, the research staff used a skin assessment tool that delineates bony prominences and requires the assessor to rate the presence or absence of a lesion at each site. A lesion on the skin surface that could be attributed to pressure, regardless of the source, was staged according to the following criteria 20 :
• Stage I: Nonblanchable erythema of intact skin: the heralding lesion of skin ulceration.
• Stage II: Partial-thickness skin loss involving the epidermis and possibly the dermis. The ulcer is superficial and presents clinically as an abrasion, blister, or shallow crater.
• Stage III: Full-thickness skin loss involving damage to or necrosis of subcutaneous tissue that may extend down to, but not through, underlying fascia. The ulcer presents clinically as a deep crater with or without undermining of adjacent tissue.
• Stage IV: Full-thickness skin loss with extensive destruction, tissue necrosis, or damage to muscle, bone, or supporting structures (ie, tendon or joint capsule). Undermining and sinus tracts may also be associated with Stage IV PrUs.
A subject's skin condition was examined according to the skin assessment chart every 24 hours over the period of data collection. The site and stage of any skin breakdown were indicated on a body chart.
A data collection form was used for recording each subject's gender, age, and treatment characteristics (medications, medical problems, and admission date). A nursing intervention checklist with common preventive and nursing measures was also completed with each skin assessment.
Procedure
Research staff were trained in scoring the PrU risk assessment scales, staging PrUs, and recording data on the skin assessment chart.Videotapes were developed and used in initial and ongoing research staff training. Subsequent on-site training was continued until interrater reliability between the investigators and research nurses reached an intraclass correlation (r) of 0.95. Interrater reliability between the investigator and the research staff was reevaluated at regular intervals and maintained at r ϭ 0.95 or better throughout the period of data collection.
After the assessor gained consent from the subjects or his or her significant other, an initial PrU assessment was performed within 48 hours of admission. The 4 PrU risk assessment scales were used by 4 independent research nurses for each patient.
Subjects were observed for PrU development every 24 hours for a maximum of 14 days. Preventive measures were documented on the nursing intervention checklist.
Data analysis
In the present study, predictive power refers to the ability of a scale to correctly classify patients with characteristics that put them at high risk for developing a PrU. Predictive power is determined by the overall considerations of sensitivity, specificity, positive predictive value, and negative predictive value.
Sensitivity is the percentage of individuals who develop a PrU who were assessed as being at risk for a PrU. A tool has good sensitivity if it correctly identifies true positives while minimizing false negatives.
Specificity is the percentage of individuals who do not develop a PrU who were assessed as being not at risk for developing a PrU. A tool has good specificity if it identifies true negatives while minimizing false positives.
A test has positive predictive value (or a high level of specificity) when the subject's risk assessment scale score is equal to or less than the cut-off for patients who develop PrUs. Similarly, a test has negative predictive value (or a high level of sensitivity) when the subject's risk assessment scale score is higher than the cut-off for patients who develop PrUs.
The definitions of these measures, which are used in epidemiology and clinical trials to examine the performance of screening or diagnostic tests, are shown in Table 1 .
Youden's index 21 (Table 2) , proposed in 1950, is an essentially equivalent index, in which J ϭ 1Ϫ(␣ ϩ
RESULTS
Subjects ranged in age from 21 to 89 years, with a mean age of 60 years. One hundred (43.5%) of the subjects were men and 130 (56.5%) were women. Seventy-four patients (32.2%) had PrUs, including 36 women with a mean age of 68.9 years and 38 men with a mean age of 68.3 years (Table 3) . Pressure ulcers were found on the sacrum (73%), buttocks (13.5%), heels (8%), and scapula (5.5%); 64.8% of PrUs were Stage II, 24.4% were Stage I, and 10.8% were Stage III. None of the patients had a Stage IV PrU.
Results of the validity screening tests for the Norton, Waterlow, Gosnell, and Braden scales are summarized in Table 4 . Based on the equivalent index assigned in Table 2 , the Gosnell scale had a better predictive power (Table 5) .
A chi-square ( 2 ) test showed a significant difference between men and women who developed PrUs (34 women [46%], 40 men [54%]; P Ͻ 03). Subjects with a PrU had a mean age of 68.9 years; those without a PrU had a mean age of 64.6 Table 1 . 
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years. A 2-tailed independent t test showed a significant difference between the 2 groups (P Ͻ .007). A Pearson product moment correlation test was performed between subjects with PrUs and the predictive power of the scales. A significant difference was found between the predictive power of the scales (P Ͻ .00001). Finally, a 2-tailed independent t test was conducted between the mean score of subjects with or without a PrU and all scales, and a significant difference was found (P Ͻ .001).
DISCUSSION
Comparison of the predictive validity of 4 commonly used PrU risk assessment scales showed that the Gosnell Scale had better predictive validity, based on Youden's index (68%; Table 5 ). Sensitivity and specificity for the Gosnell Scale were 85% and 83%, respectively. Gosnell and Pontius 22 reported sensitivity and specificity of 50% and 73%, respectively. Items included in the Gosnell scale (mental status, continence, mobility, activity, and nutrition) have been shown to impact PrU formation. This scale requires the least amount of time for completion. Because most of the subjects in the present study were from neurologic and orthopaedic units, it seems that the Gosnell Scale is more appropriate in these settings.
In the present study, the Braden Scale had a predictive value of 53% (Table 5 ). Its sensitivity, specificity, positive predictive value, and negative predictive value were 53%, 100%, 100%, and 58%, respectively. Pang and Wong 16 found that the Braden Scale had sensitivity, specificity, positive predictive value, and negative predictive value of 91%, 62%, 100%, and 96%, respectively. A study by VandenBosch et al 23 showed the specificity and sensitivity of the Braden Scale to be 59% with a cut-off point of 17. Ramundo 24 reported 100% sensitivity and 34% specificity among home care patients with a cut-off score of 18. Capobianco 25 reported 71% sensitivity, 83% specificity, 63% positive predictive value, and 88% negative predictive value for the Braden Scale. A specificity of 100% would be desirable to determine which patients would not develop a PrU.
The Norton scale had a J equaling 49% in the present study, with 66% accuracy; the positive predictive value and sensitivity were the same as found for the Braden Scale. Chan et al 26 reported the Norton Scale to be more appropriate than the Waterlow Scale for older patients. Pang and Wong 16 found 81% sensitivity, 59% specificity, 33% positive predictive value, 93% negative predictive value, and 63% accuracy for the Norton Scale. This is different from the results in the present study, perhaps because Pang and Wong selected subjects from rehabilitation units; subjects in the present study were taken from neurologic, orthopaedic, and critical care units.
Both Goldstone and Goldstone 27 and Lincoln et al 28 reported a sensitivity of 89% for the Norton Scale. Specificity in the 2 studies was vastly different: 36% for Goldstone and Goldstone 27 and 94% for Lincoln et al. 28 Similar to the Braden Scale, the 100% specificity with the Norton Scale is most appropriate for predicting patients who will not develop a PrU.
In the present study, the Waterlow Scale had a J equaling 0.465, with 77% accuracy, 63% sensitivity, 82.5% specificity, Table 2 .
THE YOUDEN'S INDEX
Test
True Test Positive Negative
True positive 1-␤ = true positive ␤ = false negative True negative ␣ = false positive 1-␣ = true negative J = 1-(␣ + ␤) Table 5 . 61% positive predictive value, and 84% negative predictive value. Compared with the other scales, the Waterlow Scale had the lowest scores. These results contrast with reports by Healey 29 and Pang and Wong. 16 Healey 29 reported 100% sensitivity and 84% specificity for the Waterlow Scale; Pang and Wong 16 reported 95% sensitivity and 45% specificity for this scale. The difference may be accounted for by the diversity of patients in the various studies.
SUBJECTS WITH PRESSURE ULCERS BY SEX AND AGE
VALIDITY SCREENING TEST RESULTS
DIAGNOSTIC AND SCREENING POWER OF 4 SCALES
A number of factors may be considered limitations of the present study, such as nursing care and the support surfaces used by patients. However, these factors were similar for all patients in the study. The effectiveness of these factors are the same in the 4 scales and, therefore cannot cause any change in the results.
Practitioners should use PrU risk assessment scales to help identify patients at risk for developing PrUs and institute preventive measures when necessary. However, use of a PrU risk assessment scale alone cannot replace a practitioner's clinical judgment in determining a patient's risk for PrU development. 30 Pressure ulcers are multidimensional, and other factors, such as mattress type, nursing care, and the patient's nutritional status and other health conditions, may have a role in PrU development and must be taken into consideration. Patient evaluations must be performed at regular intervals with a PrU risk assessment tool to help prevent PrU formation. 11 In the present study, PrU prevalence was approximately 32.2%, much higher than PrU prevalence rates reported by other studies in acute care. The most current PrU prevalence rates in acute care have been reported as 14.8%, 15%, and 15%. [5] [6] [7] Subjects in the present study had neurologic problems, such as cerebrovascular accident and intracranial hemorrhage; decreased mobility; decreased level of consciousness; inadequate nutrition; and incontinence, which may account for the higher PrU prevalence rate. In addition, nursing care in Iran is not up-to-date, and air mattresses and other pressure-relieving or pressure-reducing equipment are not used. Again, that could explain the higher prevalence rate found in the present study.
The age range of patients who developed PrUs in the present study is comparable to other studies. Hausman 9 reported that 90% of patients who developed a PrU were older than 65 years. Because life expectancy in Iran is lower than in western countries, the mean age of 68 years found in this study could be considered higher than that found in western countries.
Pressure ulcer prevalence in the first and second week of hospitalization was found to be the same as reported by Pang and Wong, 16 with 34% of PrUs occurring in the first week and 70% occurring in the second week.
Schue and Langemo 31 reported PrU prevalence by stage to be 57% for Stage II, 24% for Stage I, and 15% for Stage III. For patients in a supine position, the most common sites of PrUs were the sacrum, buttocks, heel, and occiput, which is comparable to the findings of the present study. According to Lee et al 32 , 96% of PrUs occur on the lower limbs, including 67% on the sacrum and buttocks and 29% on the heels. Leigh and Bennett 33 found the sacrum to be the most common site for PrUs (60%). Schue and Langemo 32 had a similar finding, with 46% of PrUs occurring in this area.
Many interventions can help prevent PrUs, including the use of electrical air mattresses, pedal boards, sheepskin, pillows, limb massage, and creams and changing a patient's sheets and body position. In the present study, subjects received routine nursing care in combination with a turning regimen to complement the range of multidisciplinary activities needed to manage patients at risk for PrUs. Because the patient care protocol in the present study was consistent, these interventions could not have influenced the results of the study.
CONCLUSION
Numerous PrU risk assessment tools have been developed and used in clinical practice. However, sufficient evidence for using one tool over another does not exist. The present study sought to compare the predictive validity of 4 PrU risk assessment tools: the Braden Scale, the Gosnell Scale, the Norton Scale, and the Waterlow Scale. The Gosnell Scale was found to be more appropriate for application in 2 of the primary patient groups evaluated in this study, those with neurologic conditions and those with orthopedic conditions. •
